New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

REGENXBIO Inc.  today announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial. Updates include positive functional, safety and biomarker data for RGX-202, REGENXBIO's potential ...

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

It is important to note that Ozempic and blindness are not usually connected, and vision loss is not a commonly reported or an expected side effect of this weight loss drug. However, if you are on ...

Although T-cells are well-known key players in the destruction of pancreatic beta-cells in type 1 diabetes (T1D), increasing evidence points toward a role for B-cells in disease pathogenesis. However, ...

An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...

Diabetes is a chronic condition where the body cannot regulate blood sugar levels. This occurs when the body either doesn't ...

A new study published in the journal of Frontiers in Endocrinology showed that patients with type 2 diabetes mellitus who ...